Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2012
07/05/2012CA2821863A1 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
07/05/2012CA2821340A1 Phenanthridine macrocyclic hepatitis c serine protease inhibitors
07/04/2012EP2471792A1 3-(biaryloxy) propionic acid derivative
07/04/2012EP2471789A1 Fused heterocyclic ring derivative and use thereof
07/04/2012EP2471787A1 New compounds
07/04/2012EP2471786A1 Aminopyrazole derivative
07/04/2012EP2471774A1 Piperidinyl derivatives as modulators of chemokine receptor activity
07/04/2012EP2471773A1 Piperidinyl derivatives as modulators of chemokine receptor activity
07/04/2012EP2470533A1 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors
07/04/2012EP2470530A1 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
07/04/2012EP2470527A1 Ether benzotriazole derivatives
07/04/2012EP2470526A1 Compounds and compositions as protein kinase inhibitors
07/04/2012EP2470525A1 Piperidine derivatives used as orexin antagonists
07/04/2012EP2470524A1 Pyrrolidine derivatives as nk3 receptor antagonists
07/04/2012EP2470523A1 5-methyl-piperidine derivatives as orexin receptor antagonists for the treatment of sleep disorder
07/04/2012EP2470512A1 Aromatase inhibitor
07/04/2012EP2470508A1 Cannabinoid receptor modulators
07/04/2012EP2470502A1 Tetra-substituted heteroaryl compounds and their use as mdm2 and/or mdm4 modulators
07/04/2012EP2470183A2 Heterocyclic amide compounds as protein kinase inhibitors
07/04/2012EP2062887B1 Aminopyridine derivative having aurora a-selective inhibitory activity
07/04/2012EP1863793B1 Hepatitis c virus inhibitors
07/04/2012EP1786799B1 Novel phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase
07/04/2012EP1689233B1 Bicyclic inhibitors of mek
07/04/2012EP1487805B1 Pyrimidine derivatives
07/04/2012EP1485094B1 Dosage form for oral administration of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester or its salts
07/04/2012EP1409459B1 Ecl labels having improved non-specific binding properties, methods of using and kits containing the same
07/04/2012CN202290051U 一种吡虫啉生产用加热装置 One kind of heating apparatus for the production of imidacloprid
07/04/2012CN1962641B Metalloproteinase inhibitors
07/04/2012CN1832928B 5-membered heterocycle-based p38 kinase inhibitors
07/04/2012CN1449386B Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
07/04/2012CN102548985A Substituted carbonyl compounds
07/04/2012CN102548984A Inhibitors of PI3 kinase and / or MTOR
07/04/2012CN102548983A Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor
07/04/2012CN102548982A Azetidinyl diamides as monoacylglycerol lipase inhibitors
07/04/2012CN102548973A Mesoionic pesticides
07/04/2012CN102548968A Aromatic heterocyclic derivative, and organic electroluminescent element comprising same
07/04/2012CN102548963A Novel N-substituted-pyrrolidines as inhibitors of MDM2-p53 interactions
07/04/2012CN102548558A Novel aminopyridine derivatives having Aurora A selective inhibitory action
07/04/2012CN102548557A Compounds for the reduction of beta-amyloid production
07/04/2012CN102532174A Rare earth 2, 4, 6-tripyridyl triazine complex and preparation method thereof
07/04/2012CN102532106A Synthesis method of crizotinib serving as antitumor molecular targeting medicament
07/04/2012CN102532105A Triphenylene compound containing pyridine group and application thereof
07/04/2012CN102532104A Novel aporphinoid compound and preparation method and application thereof
07/04/2012CN102532103A Quinazolinyl aryl urea derivatives and preparation method and application thereof
07/04/2012CN102532102A Preparation method for imazapyr
07/04/2012CN102532101A 2-(quinoline-8-yl)benzimidazole derivative
07/04/2012CN102532100A 1-alkyl-2-(quinolone-8-yl) benzimidazole derivative
07/04/2012CN102532099A Composition, synthesis and application of hydantoin derivatives
07/04/2012CN102532042A Aryl urea compound as well as intermediate and application thereof
07/04/2012CN102532024A Sinomenine derivative
07/04/2012CN102532016A 5-aminoquinoline-2(1H) ketone compound and synthetic method and application thereof
07/04/2012CN102532009A Compounds for inhibiting dipeptidyl peptidase, preparation method for compounds and application of compounds
07/04/2012CN102060852B Quinoline complexes, preparation method thereof, quinoline complex-containing catalyst and use of catalyst in catalysis of vinyl polymerization
07/04/2012CN101932560B Inhibitors for matrix metalloproteinases, pharmaceutical compositions containing them and their uses
07/04/2012CN101881733B Method for screening triazole monoamine oxidase inhibitor in high throughput way and compound
07/04/2012CN101851199B Substituted piperazine N-ethyl sulfonamide derivative and preparation and application thereof
07/04/2012CN101747254B Substituent indole compound and application thereof
07/04/2012CN101723911B Method for synthesizing N-aryl-1,3-oxazolin-2-one compounds
07/04/2012CN101687860B Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
07/04/2012CN101600692B Stable s-nitrosothiols, method of synthesis and use
07/04/2012CN101506165B Phenyl, pyridine and quinoline derivatives
07/04/2012CN101492444B Nitrogenous heterocyclic compounds with insecticidal activity, preparation and uses thereof
07/04/2012CN101454289B Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
07/04/2012CN101391993B Method for preparing S-omeprazole and salt thereof by forming inclusion complex with (S)-(-)-1,1'-dinaphthalene-2,2'-diol
07/04/2012CN101384183B Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions
07/04/2012CN101353343B Preparation of high-purity nolatrexed dihydrochloride dihydrate
07/04/2012CN101248064B Nitrocatechol derivatives as COMT inhibitors
07/04/2012CN101160286B Process for the preparation of ccr-2 antagonist
07/04/2012CN101087776B Organic compound, charge-transporting material, and organic electroluminescent element
07/03/2012US8212057 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
07/03/2012US8212048 Method of producing aromatic compound
07/03/2012US8212046 Process for producing crystal
07/03/2012US8212040 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
07/03/2012US8212025 Process for preparing nevirapine
07/03/2012US8211932 Organic compounds and their uses
07/03/2012US8211921 Heterocyclic inhibitors of MEK and methods of use
07/03/2012US8211920 6-oxo-1,6-dihydropyridine derivatives as inhibitors of MEK and methods of use thereof
07/03/2012US8211918 Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
07/03/2012US8211915 Biphenyl compounds useful as muscarinic receptor antagonists
07/03/2012US8211904 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
07/03/2012US8211902 Quinazolinone derivatives useful as vanilloid antagonists
07/03/2012US8211897 Inhibitors of cathepsin B
07/03/2012US8211885 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
07/03/2012US8211662 Nitroreductase enzymatic substrates
07/03/2012US8211402 CA-IX specific radiopharmaceuticals for the treatment and imaging of cancer
07/03/2012US8211401 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting PSMA
07/03/2012CA2564355C Protein kinase modulators and method of use
07/03/2012CA2538405C Novel compounds
07/03/2012CA2518766C Anti-hepatitis c virus agents and anti-hiv agents
07/03/2012CA2509406C Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
07/03/2012CA2504153C Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
07/03/2012CA2488785C Amine compound and use thereof
07/03/2012CA2478526C Substituted aryl ketones
07/03/2012CA2394086C 4-aminopiperidine derivatives and their use as medicine
07/03/2012CA2370805C Ureas as cell adhesion modulators
06/2012
06/28/2012WO2012088469A1 Faah inhibitors
06/28/2012WO2012088431A1 Faah inhibitors
06/28/2012WO2012088192A1 Electronic device including a pyrimidine compound
06/28/2012WO2012088015A2 Substituted hydroxamic acids and uses thereof
06/28/2012WO2012087960A1 Triazine derivatives for electronic applications
1 ... 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 ... 1080